Terms: = Breast cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Diagnosis
26 results:
1. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies.
Ali K; Nabeel M; Mohsin F; Iqtedar M; Islam M; Rasool MF; Hashmi FK; Hussain SA; Saeed H
Med Oncol; 2024 Apr; 41(5):112. PubMed ID: 38592510
[TBL] [Abstract] [Full Text] [Related]
2. Research Progress of cxcr4-Targeting Radioligands for Oncologic Imaging.
Wang Y; Gao F
Korean J Radiol; 2023 Sep; 24(9):871-889. PubMed ID: 37634642
[TBL] [Abstract] [Full Text] [Related]
3. A Multiple Targeting Nanoprobe for Identifying cancer Metastatic Sites Based on Detection of Various mRNAs in Circulating Tumor Cells.
Han D; Ren XH; Liao XR; He XY; Guo T; Chen XS; Pang X; Cheng SX
Nano Lett; 2023 May; 23(9):3678-3686. PubMed ID: 37052638
[TBL] [Abstract] [Full Text] [Related]
4. Expression of hypoxia inducible factor-dependent neuropeptide Y receptors Y1 and Y5 sensitizes hypoxic cells to NPY stimulation.
Medeiros PJ; Pascetta SA; Kirsh SM; Al-Khazraji BK; Uniacke J
J Biol Chem; 2022 Mar; 298(3):101645. PubMed ID: 35093384
[TBL] [Abstract] [Full Text] [Related]
5. Chemotherapy Negates the Effect of SDF1 mRNA to Distant Metastasis and Poor Overall Survival in breast cancer Patients.
Yarso KY; Bellynda M; Azmiardi A; Wasita B; Heriyanto DS; Astuti I; Hakimi M; Aryandono T
Asian Pac J Cancer Prev; 2021 Mar; 22(3):757-766. PubMed ID: 33773539
[TBL] [Abstract] [Full Text] [Related]
6. Possible Diagnostic Application of CXCL12 and cxcr4 as Tumor Markers in breast cancer Patients.
Dąbrowska E; Przylipiak A; Zajkowska M; Piskor BM; Sidorkiewicz I; Szmitkowski M; Lawicki S
Anticancer Res; 2020 Jun; 40(6):3221-3229. PubMed ID: 32487616
[TBL] [Abstract] [Full Text] [Related]
7. Efficacy evaluation and mechanism study on inhibition of breast cancer cell growth by multimodal targeted nanobubbles carrying AMD070 and ICG.
Shen D; Zhu L; Liu Y; Peng Y; Lan M; Fang K; Guo Y
Nanotechnology; 2020 Mar; 31(24):245102. PubMed ID: 32155591
[TBL] [Abstract] [Full Text] [Related]
8. The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells.
Fazi B; Proserpio C; Galardi S; Annesi F; Cola M; Mangiola A; Michienzi A; Ciafrè SA
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117166
[TBL] [Abstract] [Full Text] [Related]
9. Assessment of Copper Nanoclusters for Accurate in Vivo Tumor Imaging and Potential for Translation.
Heo GS; Zhao Y; Sultan D; Zhang X; Detering L; Luehmann HP; Zhang X; Li R; Choksi A; Sharp S; Levingston S; Primeau T; Reichert DE; Sun G; Razani B; Li S; Weilbaecher KN; Dehdashti F; Wooley KL; Liu Y
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19669-19678. PubMed ID: 31074257
[TBL] [Abstract] [Full Text] [Related]
10. Examination of methylation changes of
Shirkavand A; Boroujeni ZN; Aleyasin SA
Indian J Cancer; 2018; 55(4):366-371. PubMed ID: 30829272
[TBL] [Abstract] [Full Text] [Related]
11. Hyperosmotic intraventricular drug delivery of DV1 in the management of intracranial metastatic breast cancer in a mouse model.
Krishnamurthy S; Li J; Bodman A; Zhang C; Yang Y; An J
J Clin Neurosci; 2019 Apr; 62():207-211. PubMed ID: 30678836
[TBL] [Abstract] [Full Text] [Related]
12. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of CXC chemokine receptor 4-CXC chemokine ligand 12 axis ininvasive breast carcinoma: A potent biomarker predicting lymph node metastasis.
Dayer R; Babashah S; Jamshidi S; Sadeghizadeh M
J Cancer Res Ther; 2018; 14(2):345-350. PubMed ID: 29516917
[TBL] [Abstract] [Full Text] [Related]
14. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients.
Wang M; Ji S; Shao G; Zhang J; Zhao K; Wang Z; Wu A
Clin Transl Oncol; 2018 Jul; 20(7):906-911. PubMed ID: 29143228
[TBL] [Abstract] [Full Text] [Related]
15. Evidence of lateral transmission of aggressive features between different types of breast cancer cells.
Espinoza-Sánchez NA; Vadillo E; Balandrán JC; Monroy-García A; Pelayo R; Fuentes-Pananá EM
Int J Oncol; 2017 Nov; 51(5):1482-1496. PubMed ID: 29048610
[TBL] [Abstract] [Full Text] [Related]
16. Mesenchymal stromal cell secretome up-regulates 47 kDa cxcr4 expression, and induce invasiveness in neuroblastoma cell lines.
Shankar V; Hori H; Kihira K; Lei Q; Toyoda H; Iwamoto S; Komada Y
PLoS One; 2015; 10(3):e0120069. PubMed ID: 25774696
[TBL] [Abstract] [Full Text] [Related]
17. Risk of breast cancer with cxcr4-using HIV defined by V3 loop sequencing.
Goedert JJ; Swenson LC; Napolitano LA; Haddad M; Anastos K; Minkoff H; Young M; Levine A; Adeyemi O; Seaberg EC; Aouizerat B; Rabkin CS; Harrigan PR; Hessol NA
J Acquir Immune Defic Syndr; 2015 Jan; 68(1):30-5. PubMed ID: 25321183
[TBL] [Abstract] [Full Text] [Related]
18. Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions.
Chou CP; Huang NC; Jhuang SJ; Pan HB; Peng NJ; Cheng JT; Chen CF; Chen JJ; Chang TH
PLoS One; 2014; 9(4):e93934. PubMed ID: 24699941
[TBL] [Abstract] [Full Text] [Related]
19. Bioinformatics analysis of breast cancer bone metastasis related gene-cxcr4.
Zhang HW; Sun XF; He YN; Li JT; Guo XH; Liu H
Asian Pac J Trop Med; 2013 Sep; 6(9):732-8. PubMed ID: 23827153
[TBL] [Abstract] [Full Text] [Related]
20. Chemokines fluctuate in the progression of primary breast cancer.
Wang J; He Q; Shao YG; Ji M
Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):596-608. PubMed ID: 23543442
[TBL] [Abstract] [Full Text] [Related]
[Next]
